Technical Considerations of Single Port Ureteroneocystostomy Utilizing da Vinci SP Platform.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 20 03 2019
revised: 20 03 2019
accepted: 23 03 2019
pubmed: 4 4 2019
medline: 10 1 2020
entrez: 4 4 2019
Statut: ppublish

Résumé

To demonstrate technical considerations of a true single port robotic assisted ureteroneocystostomy using the da Vinci SP platform (Intuitive Surgical, Sunnyvale, CA). We present a 34 year-old female with an obliterative right distal ureteral stricture after undergoing a total abdominal hysterectomy for benign indications. After a period of ureteral rest, the patient elected to undergo a robotic assisted ureteroneocystostomy using the da Vinci SP platform. A refluxing ureteroneocystostomy was performed in 127 minutes, estimated blood loss was 20cc, and there were no complications. The infra-umbilical incision length was 25 mm. Intraoperative suction was achieved using flexible nasotracheal suction tubing passed alongside the 25 mm cannula. This was manipulated by the console surgeon with coordinated suction by the bedside assistant. A JJ stent was placed percutaneously with the assistance of a 14 gauge angiocatheter prior to completion of the anastomosis. To our knowledge, this represents the first case of a robotic assisted ureteroneocystostomy using the da Vinci SP platform without the use of an assistant port. This approach is safe and was completed in a similar operative time to other da Vinci systems. Single port specific considerations include novel suction device placement type, percutaneous stent advancement, and needle introduction without the use of an assistant port. Potential advantages of this technique include improved cosmesis as well as enhanced visualization and dexterity of the fully jointed instruments. Future studies are needed to assess for differences in perioperative outcomes.

Identifiants

pubmed: 30940479
pii: S0090-4295(19)30320-6
doi: 10.1016/j.urology.2019.03.020
pii:
doi:

Types de publication

Case Reports Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

236

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Kevin J Hebert (KJ)

Mayo Clinic, Department of Urology, Rochester, MN.

Jason Joseph (J)

Mayo Clinic, Department of Urology, Rochester, MN.

Matthew Gettman (M)

Mayo Clinic, Department of Urology, Rochester, MN.

Matthew Tollefson (M)

Mayo Clinic, Department of Urology, Rochester, MN.

Igor Frank (I)

Mayo Clinic, Department of Urology, Rochester, MN.

Boyd R Viers (BR)

Mayo Clinic, Department of Urology, Rochester, MN. Electronic address: Viers.Boyd@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH